2025年4月8日 星期二
首页        期刊介绍        编委会        投稿指南        期刊订阅        广告合作        联系我们        English
河北医学  2020, Vol. 26 Issue (5): 727-731    DOI: 10.3969/j.issn.1006-6233.2020.05.006
  论著 本期目录 | 过刊浏览 | 高级检索 |
同步放化疗对食管癌患者生存率及血清TSP-1 microRNA-21水平的影响
季祥, 周琳琳, 潘骥群, 周雪峰
江苏东台市人民医院肿瘤科, 江苏 东台 224200
Effect of Concurrent Radiotherapy and Chemotherapy on Survival Rate and Serum TSP-1 and MicroRNA-21 Levels in Patients with Esophageal Cancer
JI Xiang, ZHOU Linlin, PAN Jiqun, et al
Dongtai People's Hospital, Jiangsu Dongtai 224200, China
全文: PDF (1199 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的:研究同步放化疗对食管癌患者生存率及血清TSP-1、microRNA-21水平的影响。方法:选取2015年2月至2017年1月的110例食管癌患者。按照简单随机分组法分为观察组(n=59)和对照组(n=51),对照组采用序贯化放疗法治疗,观察组采用同步放化疗治疗。观察两组总缓解率、1年及2年生存率,血清凝血酶敏感蛋白-1(TSP-1)、微小RNA-21(microRNA-21)水平、卡氏(KPS)评分、不良反应情况。结果:治疗后,观察组总缓解率显著高于对照组[88.14%(52/59)vs66.67%(34/51)](P<0.05);两组1年生存率无显著差异(P>0.05),观察组2年生存率显著高于对照组[71.19%(42/59)vs33.3%(17/51)](P<0.05);血清TSP-1、microRNA-21水平均显著高于对照组[(189.63±9.20)ng/mL vs(145.86±7.49)ng/mL,(6.96±1.05)-log vs(12.82±2.04)-log](P<0.05);KPS评分显著高于对照组[(75.38±3.59)ng/mL vs(64.92±3.05)ng/mL](P<0.05);两组不良反应发生率均无统计学意义(P>0.05)。结论:同步放化疗对食管癌的临床治疗显著,可有效改善患者的临床症状,提高患者生存率,抑制肿瘤复发、转移,促进患者预后。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
季祥
周琳琳
潘骥群
周雪峰
关键词 同步放化疗食管癌近期疗效    
AbstractObjective: To study the effect of concurrent radiotherapy and chemotherapy on survival rate and serum TSP-1 and microRNA-21 levels in patients with esophageal cancer. Methods: 110 esophageal cancer patients who received therapy from February 2015 to January 2017 in our hospital were selected as research objects. According to simple random grouping method,those patients were divided into the observation group (n=59) and the control group (n=51). The control group was treated with sequential chemoradiotherapy, while the observation group was treated with concurrent radiotherapy and chemotherapy. Post-treatment comparison between both groups was made in the total remission rate, 1-year and 2-year survival rate, serum TSP-1, microRNA-21 level, Karnofsky(KPS) score, and adverse reactions. Results:After treatment, the total remission rate of the observation group was significantly higher than that of the control group[88.14%(52/59)vs66.67%(34/51)](P<0.05). There was no significant difference in 1-year survival rate between the two groups (P>0.05). The 2-year survival rate of the observation group was significantly higher than that of the control group[71.19%(42/59)vs33.3%(17/51)](P<0.05). Serum Thrombin sensitive protein-1(TSP-1) and microRNA-21 levels were significantly higher than those in the control group[(189.63±9.20)ng/mL vs(145.86±7.49)ng/mL,(6.96±1.05)-log vs(12.82±2.04)-log](P<0.05). KPS score was significantly higher than that of the control group[(75.38±3.59)ng/mL vs(64.92±3.05)ng/mL](P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Synchronous radiotherapy and chemotherapy can effectively improve the clinical symptoms, improve the survival rate of patients, inhibit tumor recurrence and metastasis, and promote the prognosis of patients.
Key wordsConcurrent radiotherapy and chemotherapy    Esophageal cancer    Short-term effects
    
基金资助:江苏省卫生厅科技项目,(编号:Z20100116)
通讯作者: 周琳琳   
引用本文:   
季祥, 周琳琳, 潘骥群, 周雪峰. 同步放化疗对食管癌患者生存率及血清TSP-1 microRNA-21水平的影响[J]. 河北医学, 2020, 26(5): 727-731.
JI Xiang, ZHOU Linlin, PAN Jiqun, et al. Effect of Concurrent Radiotherapy and Chemotherapy on Survival Rate and Serum TSP-1 and MicroRNA-21 Levels in Patients with Esophageal Cancer. HeBei Med, 2020, 26(5): 727-731.
链接本文:  
http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2020.05.006     或     http://www.hbyxzzs.cn/CN/Y2020/V26/I5/727
冀ICP备2025106803号    冀公网安备13080202000786号
版权所有 © 2016 《河北医学》杂志社
本系统由北京玛格泰克科技发展有限公司设计开发